Cutera Inc (CUTR, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Cutera Inc is a medical device company. The company is engaged in designing, development, manufacturing, marketing and servicing of laser and other energy based aesthetics systems for practitioners. Cutera Inc has a market cap of $249.840 million; its shares were traded at around $17.97 with and P/S ratio of 1.53.
For the last quarter Cutera Inc reported a revenue of $45.5 million, compared with the revenue of $47.63 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $162.7 million, an increase of 7.4% from last year. For the last five years Cutera Inc had an average revenue growth rate of 19.1% a year.
The reported loss per diluted share was $2.23 for the year, compared with the earnings per share of $0.19 in the previous year. The Cutera Inc had an operating margin of -8.23%, compared with the operating margin of 7.31% a year before. The 10-year historical median operating margin of Cutera Inc is -8.53%. The profitability rank of the company is 5 (out of 10).
At the end of the fiscal year, Cutera Inc has the cash and cash equivalents of $26.1 million, compared with $14.2 million in the previous year. The company had no long term debt. Cutera Inc has a financial strength rank of 8 (out of 10).
At the current stock price of $17.97, Cutera Inc is traded at 20.3% discount to its historical median P/S valuation band of $22.56. The P/S ratio of the stock is 1.53, while the historical median P/S ratio is 1.91. The stock lost 66.05% during the past 12 months.
For the complete 20-year historical financial data of CUTR, click here.
